001026004 001__ 1026004
001026004 005__ 20250204113851.0
001026004 0247_ $$2doi$$a10.3390/molecules29051089
001026004 0247_ $$2datacite_doi$$a10.34734/FZJ-2024-03260
001026004 0247_ $$2pmid$$a38474602
001026004 0247_ $$2WOS$$aWOS:001183457000001
001026004 037__ $$aFZJ-2024-03260
001026004 082__ $$a540
001026004 1001_ $$0P:(DE-Juel1)132740$$aHumpert, Swen$$b0$$ufzj
001026004 245__ $$aRadiosynthesis and In Vitro Evaluation of [11C]tozadenant as Adenosine A2A Receptor Radioligand
001026004 260__ $$aBasel$$bMDPI$$c2024
001026004 3367_ $$2DRIVER$$aarticle
001026004 3367_ $$2DataCite$$aOutput Types/Journal article
001026004 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1714655115_25204
001026004 3367_ $$2BibTeX$$aARTICLE
001026004 3367_ $$2ORCID$$aJOURNAL_ARTICLE
001026004 3367_ $$00$$2EndNote$$aJournal Article
001026004 520__ $$aTozadenant (4-hydroxy-N-(4-methoxy-7-morpholinobenzo[d]thiazol-2-yl)-4-methylpiperidine-1-carboxamide) is a highly selective adenosine A2A receptor (A2AR) antagonist and a promisinglead structure for the development of A2AR-selective positron emission tomography (PET) probes.Although several 18F-labelled tozadenant derivatives showed favorable in vitro properties, recentin vivo PET studies observed poor brain penetration and lower specific binding than anticipated fromthe in vitro data. While these findings might be attributable to the structural modification associatedwith 18F-labelling, they could also reflect inherent properties of the parent compound. However,PET studies with radioisotopologues of tozadenant to evaluate its cerebral pharmacokinetics andbrain distribution are still lacking. In the present work, we applied N-Boc-O-desmethyltozadenantas a suitable precursor for the preparation of [O-methyl-11C]tozadenant ([11C]tozadenant) by Omethylationwith [11C]methyl iodide followed by acidic deprotection. This approach afforded[11C]tozadenant in radiochemical yields of 18 ± 2%, with molar activities of 50–60 GBq/μmol(1300–1600 mCi/μmol) and radiochemical purities of 95 ± 3%. In addition, in vitro autoradiographyin pig and rat brain slices demonstrated the expected striatal accumulation pattern and confirmedthe A2AR specificity of the radioligand, making it a promising tool for in vivo PET studies on thecerebral pharmacokinetics and brain distribution of tozadenant.
001026004 536__ $$0G:(DE-HGF)POF4-5253$$a5253 - Neuroimaging (POF4-525)$$cPOF4-525$$fPOF IV$$x0
001026004 588__ $$aDataset connected to CrossRef, Journals: juser.fz-juelich.de
001026004 7001_ $$0P:(DE-Juel1)156407$$aSchneider, Daniela$$b1
001026004 7001_ $$0P:(DE-Juel1)131831$$aLang, Markus$$b2$$ufzj
001026004 7001_ $$0P:(DE-Juel1)131847$$aSchulze, Annette$$b3$$ufzj
001026004 7001_ $$0P:(DE-Juel1)175142$$aNeumaier, Felix$$b4
001026004 7001_ $$0P:(DE-Juel1)131824$$aHolschbach, Marcus$$b5
001026004 7001_ $$0P:(DE-Juel1)131810$$aBier, Dirk$$b6
001026004 7001_ $$0P:(DE-Juel1)166419$$aNeumaier, Bernd$$b7$$eCorresponding author
001026004 773__ $$0PERI:(DE-600)2008644-1$$a10.3390/molecules29051089$$gVol. 29, no. 5, p. 1089 -$$n5$$p1089$$tMolecules$$v29$$x1420-3049$$y2024
001026004 8564_ $$uhttps://juser.fz-juelich.de/record/1026004/files/molecules-29-01089.pdf$$yOpenAccess$$zStatID:(DE-HGF)0510
001026004 8564_ $$uhttps://juser.fz-juelich.de/record/1026004/files/molecules-29-01089.gif?subformat=icon$$xicon$$yOpenAccess$$zStatID:(DE-HGF)0510
001026004 8564_ $$uhttps://juser.fz-juelich.de/record/1026004/files/molecules-29-01089.jpg?subformat=icon-1440$$xicon-1440$$yOpenAccess$$zStatID:(DE-HGF)0510
001026004 8564_ $$uhttps://juser.fz-juelich.de/record/1026004/files/molecules-29-01089.jpg?subformat=icon-180$$xicon-180$$yOpenAccess$$zStatID:(DE-HGF)0510
001026004 8564_ $$uhttps://juser.fz-juelich.de/record/1026004/files/molecules-29-01089.jpg?subformat=icon-640$$xicon-640$$yOpenAccess$$zStatID:(DE-HGF)0510
001026004 909CO $$ooai:juser.fz-juelich.de:1026004$$pdnbdelivery$$pdriver$$pVDB$$popen_access$$popenaire
001026004 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)132740$$aForschungszentrum Jülich$$b0$$kFZJ
001026004 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)156407$$aForschungszentrum Jülich$$b1$$kFZJ
001026004 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131831$$aForschungszentrum Jülich$$b2$$kFZJ
001026004 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131847$$aForschungszentrum Jülich$$b3$$kFZJ
001026004 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)175142$$aForschungszentrum Jülich$$b4$$kFZJ
001026004 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131824$$aForschungszentrum Jülich$$b5$$kFZJ
001026004 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131810$$aForschungszentrum Jülich$$b6$$kFZJ
001026004 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)166419$$aForschungszentrum Jülich$$b7$$kFZJ
001026004 9131_ $$0G:(DE-HGF)POF4-525$$1G:(DE-HGF)POF4-520$$2G:(DE-HGF)POF4-500$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$9G:(DE-HGF)POF4-5253$$aDE-HGF$$bKey Technologies$$lNatural, Artificial and Cognitive Information Processing$$vDecoding Brain Organization and Dysfunction$$x0
001026004 9141_ $$y2024
001026004 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2023-10-22
001026004 915__ $$0LIC:(DE-HGF)CCBY4$$2HGFVOC$$aCreative Commons Attribution CC BY 4.0
001026004 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2023-10-22
001026004 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2023-10-22
001026004 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
001026004 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2023-10-22
001026004 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bMOLECULES : 2022$$d2024-12-16
001026004 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2024-12-16
001026004 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2024-12-16
001026004 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2024-04-10T15:26:48Z
001026004 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2024-04-10T15:26:48Z
001026004 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Anonymous peer review$$d2024-04-10T15:26:48Z
001026004 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2024-12-16
001026004 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2024-12-16
001026004 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2024-12-16
001026004 915__ $$0StatID:(DE-HGF)1150$$2StatID$$aDBCoverage$$bCurrent Contents - Physical, Chemical and Earth Sciences$$d2024-12-16
001026004 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2024-12-16
001026004 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2024-12-16
001026004 920__ $$lyes
001026004 9201_ $$0I:(DE-Juel1)INM-5-20090406$$kINM-5$$lNuklearchemie$$x0
001026004 980__ $$ajournal
001026004 980__ $$aVDB
001026004 980__ $$aUNRESTRICTED
001026004 980__ $$aI:(DE-Juel1)INM-5-20090406
001026004 9801_ $$aFullTexts